Vestmark Advisory Solutions’s Takeda Pharmaceutical TAK Stock Holding History

Vestmark Advisory Solutions’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.64M	Buy	351,770 +5,948	+2%	+$98.4K	0.05%	346
2026 Q1	$6.4M	Buy	345,822 +156,248	+82%	+$2.74M	0.07%	286
2025 Q4	$2.96M	Buy	+189,574	New	+$2.71M	0.04%	457
2025 Q3	–	Sell	-63,862	Closed	-$987K	–	991
2025 Q2	$987K	Buy	+63,862	New	+$944K	0.01%	500
2024 Q4	–	Sell	-55,528	Closed	-$790K	–	608
2024 Q3	$790K	Sell	55,528 -17,205	-24%	-$244K	0.03%	335
2024 Q2	$941K	Buy	72,733 +4,541	+7%	+$60.1K	0.04%	318
2024 Q1	$947K	Buy	68,192 +3,272	+5%	+$47.6K	0.04%	321
2023 Q4	$926K	Buy	64,920 +1,290	+2%	+$18.3K	0.05%	294
2023 Q3	$984K	Buy	63,630 +870	+1%	+$13.5K	0.07%	243
2023 Q2	$986K	Sell	62,760 -594	-0.9%	-$9.73K	0.04%	449
2023 Q1	$1.04M	Buy	63,354 +2,698	+4%	+$43K	0.05%	426
2022 Q4	$946K	Sell	60,656 -1,564	-3%	-$21.8K	0.05%	430
2022 Q3	$807K	Buy	+62,220	New	+$865K	0.05%	438

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vestmark Advisory Solutions's TAK Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Takeda Pharmaceutical (TAK) stake by 1.7% in Q2 2026, buying an estimated $98.4K and bringing the position to 351,770 shares worth $5.64M. The position accounts for 0.05% of the portfolio, ranked #346.

Vestmark Advisory Solutions first reported a position in TAK in Q3 2022 and has held it in 13 quarters since. The position peaked at $6.4M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Vestmark Advisory Solutions held 351,770 shares of Takeda Pharmaceutical worth $5.64M as of Q2 2026.
Vestmark Advisory Solutions bought 5,948 Takeda Pharmaceutical shares in Q2 2026, an estimated $98.4K.
Takeda Pharmaceutical made up 0.05% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #346 holding.
Vestmark Advisory Solutions first reported a position in Takeda Pharmaceutical in Q3 2022 and has held it in 13 quarters since.
Vestmark Advisory Solutions's Takeda Pharmaceutical position peaked at $6.4M in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.